PBS Website Update - 1 April 2025
Page last updated: 1 April 2025
The Schedule of Pharmaceutical Benefits has been updated. New, Amended and Deleted items can be found on the Summary of Changes page.
The following updates have also been made to the PBS Website on the dates specified.
- Expanded access to empagliflozin for type 2 diabetes patients with high cardiovascular risk - 1 April 2025
- Shortages of hormone replace therapy (HRT) patches: PBS subsidy and substitution of Estradot, Estraderm MX and overseas alternatives - 1 April 2025
- 1 April 2025 designated brand list – minimum stockholding requirements - 1 April 2025
- PBS Continued Dispensing Arrangements - 1 April 2025
- PBS Arrangements to Support Australians Affected by Natural Disasters and Emergencies - 1 April 2025
- First New Brand Price Reductions - 1 April 2025
- Formulary Allocations - 1 April 2025
- Ex-manufacturer price - 1 April 2025
- Medicine Status Website - 1 April 2025
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 April 2025
- Current Price Disclosure cycle – 2025 April - 28 March 2025
- Review of PBS items for prescribing by nurse practitioners and endorsed midwives - 27 March 2025
- Drug Utilisation Sub-Committee (DUSC) Outcome Statement - 21 March 2025
- PBAC Public Summary Documents (first time decisions not to recommend and deferrals)– November 2024 meeting - 21 March 2025
- Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 14 March 2025
- New Minimum Stockholding Requirement Fact Sheets and Updated Web Content - 12 March 2025
- PBAC Public Summary Documents – November 2024 meeting - 7 March 2025
- Update to Continued Dispensing Arrangements – Emergency Measures - 5 March 2025
- Shortages of hormone replace therapy (HRT) patches: PBS subsidy and substitution of Estradot, Estraderm MX and overseas alternatives - 4 March 2025
- PBS item supply for formerly private prescription items (e.g. Yaz® and Yasmin® – listed from 1 March) - 1 March 2025
